BioXcel Therapeutics Inc (NASDAQ:BTAI)’s traded shares stood at 78653.0 during the last session, with the company’s beta value hitting 0.06.The BTAI share’s 52-week high remains
In last trading session, BioXcel Therapeutics Inc (NASDAQ:BTAI) saw 1.16 million shares changing hands with its beta currently measuring -0.02. Company’s recent per share price
During the last session, BioXcel Therapeutics Inc (NASDAQ:BTAI)’s traded shares were 96706.0, with the beta value of the company hitting -0.13. At the end of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne